Content creators mean business
Social media influencers are flipping the rules by first getting followers and then launching products and ...
An international team led by Perelman School of Medicine at the University of Pennsylvania researchers found that commonly used blood pressure medications did not impact outcomes among hospitalised Covid-19 patients.
The study, published in The Lancet Respiratory Medicine, revealed that there is no risk for patients continuing these medications while hospitalised for Covid-19.
For the study, the researchers analysed whether ACE inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs) — two classes of medications to treat high blood pressure — could help lessen Covid-19 complications or lead to severity.
High blood pressure medications reduce Covid-19 death risk: Study
The researchers enrolled 152 participants across several countries between March 31 and August 20, 2020, who were hospitalised with Covid-19 and already using one of the medications
Some studies had earlier suggested that such medications could aggravate cellular receptors for the SARS-CoV-2 virus, potentially aiding viral replication.
However, it was also considered that some effects of these medications could be protective against SARS-CoV-2.
BP drugs may improve Covid-19 survival rates: Study
Senior author Julio A. Chirinos, MD, Ph D, an associate professor of Cardiovascular Medicine at the Perelman School of Medicine, said: “Our trial results importantly show that these medications can be safely continued for patients hospitalised with Covid-19.”
To study the impact, the authors then developed an innovative global rank score to classify patient outcomes based on four factors: time to death, length of time supported by mechanical ventilation, length of time on renal replacement therapy, and a modified sequential organ failure assessment score.
The findings of the team suggested that discontinuation of ACEIs and ARBs compared with continuation of these medications had no effect on the global rank score.
First author Jordana B. Cohen, MD, MSCE, an assistant professor in the division of Renal-Electrolyte and Hypertension, said: "Now we have high-quality evidence to support our recommendation that patients continue to take these medications as prescribed."
Social media influencers are flipping the rules by first getting followers and then launching products and ...
Paneer, once alien to the South, has found a lucrative market in Chennai
WPP agency Wunderman Thompson has launched its annual Future 100 report, lifting the lid on trends shaping the ...
Carriers claim that all measures — including pre-flight tests, cabin sanitisation and fresh air inflow — have ...
What filters should you apply when mining for under-the-radar small-cap stocks? Read on to find more
High valuation, intensely competitive landscape and small cap nature of the stock are key risks.
Amid choppiness, the benchmark indices slipped marginally; approach the week with caution
SBI Cards (₹1,032.7): Witnesses fresh breakoutBetween September and December last year, the stock of SBI Cards ...
A virus swept aside 2020 plans to mark the 250th year of the birth of Beethoven. We need the German composer’s ...
Former MLA and farmer leader VM Singh on the violence that followed the January 26 tractor rally, the impasse ...
The birds, locally known as the Garuda, help farmers by killing rats and other farm pests
A mysterious new exhibit has been the centre of attraction at the gallery of Modern Art. This art work has ...
Social media influencers are flipping the rules by first getting followers and then launching products and ...
WPP agency Wunderman Thompson has launched its annual Future 100 report, lifting the lid on trends shaping the ...
Paneer, once alien to the South, has found a lucrative market in Chennai
The Flipkart kids playing adults are back — this time to push the home grown e-commerce marketplace’s grocery ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...